A New York Times article from May 2014 reported that, according to data from the CDC, more than 10,000 American toddlers aged younger than 4 years are being medicated for ADHD.ĭespite the fact that the most recent AAP guidelines for ADHD treatment are restricted to patients aged 4 to 18 years, the vast majority of prescriptions for children aged younger than 4 years are written by primary care providers. Johns Hopkins University School of MedicineĪ recent review of Medicaid data from 36 states reported that 1% to 2% of children aged younger than 4 years are receiving psychotropic medication, with 61% of those for ADHD. Member, AACAP Committee on Infant and Preschool PsychiatryĪssistant professor, department of psychiatry Maryland Behavioral Health Integration in Pediatric Primary Care We welcome you to share your own impressions of this topic by commenting online at /Pediatrics. Read comment from an expert whom Infectious Diseases in Children asked for her opinion on whether pharmacological intervention should be recommended to children aged younger than 4 years, and if the benefit of treatment significantly improves the quality of life for the child and the family. Currently, the practice is hampered by scant clinical studies on the effects of stimulants on preschoolers, as well as varying degrees of patient response and the chance of unforeseen behavioral and cognitive side effects. While treating young children remains poorly understood, it has become more widely practiced in recent years. Stimulant medication management of attention-deficit/hyperactivity disorder in children as young as age 4 years is a problem faced by many physicians. If you continue to have this issue please contact to Healio
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |